Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins

Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins

US Patent 11395846 · Granted Jul 26, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions comprising TLIA-Ig fusion protein for the regulation of T regulator2021
Method for in vivo expansion of T regulatory cells2021
System and method for experiencing higher dimensionality data using lower dimens2020
Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonist2020
Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonist2020
Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonist2020
Tumor vaccine2019
Flexible architecture for notifying applications of state changes2019
Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonist2017
Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonist2017
Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonist2017
Compositions comprising TL1A-Ig fusion protein for the regulation of T regulator2017